SEARCH

SEARCH BY CITATION

References

  • Arnold, J.N., Wormald, M.R., Sim, R.B., Rudd, P.M. and Dwek, R.A. (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25, 2150.
  • Baker, K., Qiao, S.W., Kuo, T., Kobayashi, K., Yoshida, M., Lencer, W.I. and Blumberg, R.S. (2009) Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin. Immunopathol. 31, 223236.
  • Basaran, P. and Rodríguez-Cerezo, E. (2008) Plant molecular farming: opportunities and challenges. Crit. Rev. Biotechnol. 28, 153172.
  • Bebb, G., Smith, C., Rorke, S., Boland, W., Nicacio, L., Sukhoo, R. and Brade, A. (2011) Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy. Cancer Chemother. Pharmacol. 67, 837845.
  • Beck, A., Wagner-Rousset, E., Bussat, M.C., Lokteff, M., Klinguer-Hamour, C., Haeuw, J.F., Goetsch, L., Wurch, T., Dorsselaer, A.V. and Corvaïa, N. (2008) Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. Curr. Pharm. Biotechnol. 9, 482501.
  • Beck, A., Wurch, T., Bailly, C. and Corvaia, N. (2010) Strategies and challenges for the next generation of therapeutic antibodies. Nat. Rev. Immunol. 10, 345352.
  • Berger, C., Krengel, U., Stang, E., Moreno, E. and Helene Madshus, I. (2011) Nimotuzumab and cetuximab block ligand-independent EGF receptor signaling efficiently at different concentrations. J. Immunother. 34, 550555.
  • Bergh, J., Nilsson, K., Ekman, R. and Giovanella, B. (1985) Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol. Microbiol. Immunol. Scand. A, 93, 133147.
  • Bigge, J.C., Patel, T.P., Bruce, J.A., Goulding, P.N., Charles, S.M. and Parekh, R.B. (1995) Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal. Biochem. 230, 229238.
  • Bode, U., Buchen, S., Warmuth-Metz, M., Pietsch, T., Bach, F. and Fleischhack, G. (2007) Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents. J. Clin. Oncol. 25, 2006.
  • Bode, U., Windelberg, M., Massimino, M., Khuhlaeva, E., Warmuth-Metz, M., Kortmann, R.D., Bach, F. and Fleischhack, G. (2008) Phase III trial of nimotuzumab for the treatment of newly diagnosed diffuse intrinsic pontine gliomas in children and adolescents. J. Clin. Oncol. 26, 2058.
  • Boland, W. and Bebb, G. (2010) The emerging role of nimotuzumab in the treatment of non-small cell lung cancer. Biologics, 4, 289298.
  • Boothe, J., Nykiforuk, C., Shen, Y., Zaplachinski, S., Szarka, S., Kuhlman, P., Murray, E., Morck, D. and Moloney, M.M. (2010) Seed-based expression systems for plant molecular farming. Plant Biotechnol. J. 8, 588606.
  • Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248254.
  • Brereton, H.M., Chamberlain, D., Yang, R., Tea, M., McNeil, S., Coster, D.J. and Williams, K.A. (2007) Single chain antibody fragments for ocular use produced at high levels in a commercial wheat variety. J. Biotechnol. 129, 539546.
  • Carney, D.N., Gazdar, A.F., Bepler, G., Guccion, J.G., Marangos, P.J., Moody, T.W., Zweig, M.H. and Minna, J.D. (1985) Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 45, 29132923.
  • Crombet, T., Rak, J., Perez, R. and Viloria Petit, A. (2002) Antiproliferative, antiangiogenic and proapoptotic activity of hR3: a humanized anti EGFR antibody. Int. J. Cancer, 101, 567575.
  • Crombet, T., Osorio, M., Cruz, T., Roca, C., del, C.R., Mon, R., Iznaga-Escobar, N., Figueredo, R., Koropatnick, J., Renginfo, E., Fernandez, E., Alvarez, D., Torres, O., Ramos, M., Leonard, I., Perez, R. and Lage, A. (2004) Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients. J. Clin. Oncol. 22, 16461654.
  • Crombet, T., Neninger, E., Catalá, M., García, B., Rupalé, I.L., Martínez, L., González, G., Pérez, R., Lage, A., O'Mahony, D. and Dennis, P.A. (2006) Treatment of NSCLC patients with an EGF-based cancer vaccine: report of a Phase I trial. Commentary. Cancer Biol. Ther. 5, 145151.
  • De Muynck, B., Navarre, C., Nizet, Y., Stadlmann, J. and Boutry, M. (2009) Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells. Transgenic Res. 18, 467482.
  • De Muynck, B., Navarre, C. and Boutry, M. (2010) Production of antibodies in plants: status after twenty years. Plant Biotechnol. J. 8, 529563.
  • ElBakri, A., Nelson, P.N. and Abu Odeh, R.O. (2010) The state of antibody therapy. Hum. Immunol. 71, 12431250.
  • Ferro, W., Geada, D., Guevara, Y., Padilla, S., Conde, A., Álvarez, T., Medina, Y., González, T., Wood, M. and Valdés, R. (2012) Prolonged stability of the plantibody HB-01 directed against the hepatitis B surface antigen in cryo-preserved tobacco leaves. Biologicals, 38, 415419.
  • Fischer, R., Schillberg, S., Hellwig, S., Twyman, R.M. and Drossard, J. (2012) GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol. Adv. 30, 434439.
  • Foresti, O. and Denecke, J. (2008) Intermediate organelles of the plant secretory pathway: identity and function. Traffic, 9, 15991612.
  • Franconi, R., Demurtas, O.C. and Massa, S. (2010) Plant-derived vaccines and other therapeutics produced in contained systems. Expert Rev. Vaccines, 9, 877892.
  • Garrido, G., Tikhomirov, I.A., Rabasa, A., Yang, E., Gracia, E., Iznaga, N., Fernández, L.E., Crombet, T., Kerbel, R. and Pérez, R. (2011) Bivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profile. Cancer Biol. Ther. 11, 373382.
  • Gomord, V., Fitchette, A.C., Menu-Bouaouiche, L., Saint-Jore-Dupas, C., Plasson, C., Michaud, D. and Faye, L. (2010) Plant specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol. J. 8, 564587.
  • Grohs, B.M., Niu, Y., Veldhuis, L.J., Trabelsi, S., Garabagi, F., Hassell, J.A., McLean, M.D. and Hall, J.C. (2010) Plant-Produced Trastuzumab Inhibits the Growth of HER2 Positive Cancer Cells. J. Agric. Food Chem. 58, 1005610063.
  • Guile, G.R., Rudd, P.M., Wing, D.R., Prime, S.B. and Dwek, R.A. (1996) A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 240, 210226.
  • Hiatt, A., Cafferkey, R. and Bowdish, K. (1989) Production of antibodies in transgenic plants. Nature, 342, 7678.
  • Iznaga-Escobar, N., Morales-Morales, A., Ducongé, J., Caballero, I., Fernandez, E. and Gómez, J.A. (1998) Pharmacokinetics, biodistribution and dosimetry of 99mTc-labeled anti-human epidermal growth factor receptor humanized monoclonal antibody R3 in rats. Nucl. Med. Biol. 25, 1723.
  • Jamal, A., Ko, K., Kim, H.S., Choo, Y.K., Joung, H. and Ko, K. (2009) Role of genetic factors and environmental conditions in recombinant protein production for molecular farming. Biotechnol. Adv. 27, 914923.
  • Karg, S.R. and Kallio, P.T. (2009) The production of biopharmaceuticals in plant systems. Biotechnol. Adv. 27, 879894.
  • Ko, K., Tekoah, Y., Rudd, P.M., Harvey, D.J., Dwek, R.A., Spitsin, S., Hanlon, C.A., Rupprecht, C., Dietzschold, B. and Golovkin, M. (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. USA, 100, 80138018.
  • Ko, K., Steplewski, Z., Glogowska, M. and Koprowski, H. (2005) Inhibition of tumor growth by plant-derived mAb. Proc. Natl. Acad. Sci. USA, 102, 70267030.
  • Komarova, T.V., Baschieri, S., Donini, M., Marusic, C., Benvenuto, E. and Dorokhov, Y.L. (2010) Transient expression systems for plant-derived biopharmaceuticals. Expert Rev. Vaccines, 9, 859876.
  • Komarova, T.V., Kosorukov, V.S., Frolova, O.Y., Petrunia, I.V., Skrypnik, K.A., Gleba, Y.Y. and Dorokhov, Y.L. (2011) Plant-made trastuzumab (herceptin) inhibits HER2/Neu+ cell proliferation and retards tumor growth. PLoS ONE, 6, e17541.
  • Kuo, T.T., Baker, K., Yoshida, M., Qiao, S.W., Aveson, V.G., Lencer, W.I. and Blumberg, R.S. (2010) Neonatal Fc receptor: from immunity to therapeutics. J. Clin. Immunol. 30, 777789.
  • Kuster, B., Wheeler, S.F., Hunter, A.P., Dwek, R.A. and Harvey, D.J. (1997) Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal. Biochem. 250, 82101.
  • Ledón, N., Casacó, A., Casanova, E. and Beausoleil, I. (2011) Comparative analysis of binding affinities to epidermal growth factor receptor of monoclonal antibodies nimotuzumab and cetuximab using different experimental animal models. Placenta, 32, 531534.
  • Levitzki, A. and Gazit, A. (1995) Tyrosine kinase inhibition: an approach to drug development. Science, 267, 17821788.
  • Loos, A., Van Droogenbroeck, B., Hillmer, S., Grass, J., Kunert, R., Cao, J., Robinson, D.G., Depicker, A. and Steinkellner, H. (2011) Production of monoclonal antibodies with a controlled N-glycosylation pattern in seeds of Arabidopsis thaliana. Plant Biotechnol. J. 9, 179192.
  • Ludwig, D.L., Witte, L., Hicklin, D.J., Prewett, M., Bassi, R., Burtrum, D., Pereira, D.S., Jimenez, X., Fox, F. and Saxena, B. (2004) Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed. Hum. Antibodies, 13, 8190.
  • Ma, S. and Wang, A. (2012) Molecular farming in plants: an overview. In Molecular Farming in Plants: Recent Advances and Future Prospects (Wang, A. and Ma, S., eds), pp. 120. Dordrecht, the Netherlands: Springer.
  • Macías, A., Pérez Rodríguez, R. and Lage, A. (1985) Studies on the epidermal growth factor: II. Development of an analysis radioreceptor for determining picomole quantities. Interferón y Biotecnología, 2, 115127.
  • Matamoros, L.E., Kalume, D.E., Calvo, L., Fernández, M., Vallin, A. and Roepstorff, P. (2001) Characterization of a recombinant monoclonal antibody by mass spectrometry combined with liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 752, 247261.
  • Mateo, C., Moreno, E., Amour, K., Lombardero, J. and Harris, W. (1997) Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology, 3, 7181.
  • Montesino, R., Calvo, L., Vallin, A., Rudd, P.M., Harvey, D.J. and Cremata, J.A. (2012) Structural characterization of N-linked oligosaccharides on monoclonal antibody Nimotuzumab through process development. Biologicals, 40, 288298.
  • Morales, A., Ducongé, J., Caballero, I., Núñez, G., Fernández, E. and Iznaga, N. (1999) Biodistribution of 99mTc-labeled anti-human epidermal growth factor receptor (EGF-R) humanized monoclonal antibody h-R3 in a xenograft model of human lung adenocarcinoma. Nucl. Med. Biol. 26, 275279.
  • Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139, 271279.
  • Nimmerjahn, F. and Ravetch, J.V. (2006) Fcγ receptors: old friends and new family members. Immunity, 24, 1928.
  • Obembe, O.O., Popoola, J.O., Leelavathi, S. and Reddy, S.V. (2011) Advances in plant molecular farming. Biotechnol. Adv. 29, 210222.
  • Osorio, M., Cruz, T., del Castillo, R., Roca, C., Azcue, M., Neninger, E., Alert, J., Jiménez, J., Rodríguez, E., Gracias, E., Mulén, B., Wilkinson, B., de Armas, E.L., Pérez, K., Pineda, I., Frómeta, M., Leonard, I., Mullens, V., Viada, C., Luaces, P., Torres, O., Iznaga, N. and Crombet, T. (2010) Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck. Cancer Biol. Ther. 9, 343349.
  • Paul, M. and Ma, J.K.C. (2011) Plant-made pharmaceuticals: leading products and production platforms. Biotechnol. Appl. Biochem. 58, 5867.
  • Peters, J. and Stoger, E. (2011) Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies. Hum. Vaccin. 7, 367374.
  • PhRMA. (2011). Report: Medicines in Development – Biotechnology. Presented by America's biopharmaceutical research companies.
  • Pogue, G.P., Vojdani, F., Palmer, K.E., Hiatt, E., Hume, S., Phelps, J., Long, L., Bohorova, N., Kim, D. and Pauly, M. (2010) Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnol. J. 8, 638654.
  • Pujol, M., Ramírez, N.I., Ayala, M., Gavilondo, J.V., Valdés, R., Rodríguez, M., Brito, J., Padilla, S., Gómez, L., Reyes, B., Peral, R., Pérez, M., Marcelo, J.L., Milá, L., Sánchez, R.F., Páez, R., Cremata, J.A., Enríquez, G., Mendoza, O., Ortega, M. and Borroto, C. (2005) An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification. Vaccine, 23, 18331837.
  • Rademacher, T., Sack, M., Arcalis, E., Stadlmann, J., Balzer, S., Altmann, F., Quendler, H., Stiegler, G., Kunert, R., Fischer, R. and Stoger, E. (2008) Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol. J. 6, 189201.
  • Ramakrishnan, M.S., Eswaraiah, A., Crombet, T., Piedra, P., Saurez, G., Iyer, H. and Arvind, A.S. (2009) Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin. MAbs, 1, 4148.
  • Ramírez, N., Ayala, M., Lorenzo, D., Palenzuela, D., Herrera, L., Doreste, V., Pérez, M., Gavilondo, J.V. and Oramas, P. (2002) Expression of a single-chain Fv antibody fragment specific for the hepatitis B surface antigen in transgenic tobacco plants. Transgenic Res. 11, 6164.
  • Ramírez, N., Rodríguez, M., Ayala, M., Cremata, J., Pérez, M., Martínez, A., Linares, M., Hevia, Y., Páez, R., Valdés, R., Gavilondo, J.V. and Selman-Housein, G. (2003) Expression and characterization of an anti (hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen. Biotechnol. Appl. Biochem. 38, 223230.
  • Ramos-Suzarte, M., Lorenzo-Luaces, P., Lazo, N.G., Perez, M.L., Soriano, J.L., González, C.E., Hernadez, I.M., Albuerne, Y.A., Moreno, B.P. and Alvarez, E.S. (2012) Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy. Cancer Biol. Ther. 13, 600605.
  • Rodríguez, M., Ramírez, N.I., Ayala, M., Freyre, F., Pérez, L., Triguero, A., Mateo, C., Selman-Housein, G., Gavilondo, J. and Pujol, M. (2005) Transient expression in tobacco leaves of an aglycosylated recombinant antibody against the epidermal growth factor receptor. Biotechnol. Bioeng. 89, 188194.
  • Roopenian, D.C. and Akilesh, S. (2007) FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7, 715725.
  • Rybicki, E.P. (2009) Plant-produced vaccines: promise and reality. Drug Discov. Today, 14, 1624.
  • Sainsbury, F., Sack, M., Stadlmann, J., Quendler, H., Fischer, R. and Lomonossoff, G.P. (2010) Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody. PLoS ONE, 5, e13976.
  • Sanchez, A., Ramos, Y., Solano, Y., Gonzalez, L.J., Besada, V., Betancourt, L., Gil, J., Alvarez, F., Rodriguez, M. and Perez, L. (2007) Double acylation for identification of amino-terminal peptides of proteins isolated by polyacrylamide gel electrophoresis. Rapid Commun. Mass Spectrom. 21, 22372244.
  • Sánchez, B., Suárez, E., Garrido, G., Hernández, T., Pérez, R., Ullrich, A. and Fernández, L.E. (2006) Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvant. Int. J. Cancer, 119, 21902199.
  • Schillberg, S., Zimmermann, S., Voss, A. and Fischer, R. (1999) Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum. Transgenic Res. 8, 255263.
  • Schwarz, A. and Steinstraber, A. (1987) A novel approach to Tc-99m-labeled monoclonal antibodies. J. Nucl. Med. 28, 721.
  • Sharma, A.K. and Sharma, M.K. (2009) Plants as bioreactors: recent developments and emerging opportunities. Biotechnol. Adv. 27, 811832.
  • Shushan, A., Rojansky, N., Laufer, N., Klein, B.Y., Shlomai, Z., Levitzki, R., Hartzstark, Z. and Ben-Bassat, H. (2004) The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth. Hum. Reprod. 19, 19571967.
  • Sibéril, S., Dutertre, C.A., Fridman, W.H. and Teillaud, J.L. (2007) FcγR: the key to optimize therapeutic antibodies? Crit. Rev. Oncol. Hematol. 62, 2633.
  • Soriano, J.L., Batista, N. and Lima, M. (2007) Phase I clinical study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody (Nimotuzumab) in combination with chemotherapy in patients with locally advanced breast cancer. Preliminary results. Eur. J. Cancer Suppl. 5, 116117.
  • Streatfield, S.J. (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol. J. 5, 215.
  • Strumberg, D., Schultheis, B., Scheulen, M.E., Hilger, R.A., Krauss, J., Marschner, N., Lordick, F., Bach, F., Reuter, D. and Edler, L. (2012) Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. Invest. New Drugs, 30, 11381143.
  • Takeda, M., Okamoto, I., Nishimura, Y. and Nakagawa, K. (2011) Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer. Lung Cancer Targets Ther. 2, 5967.
  • Talavera, A., Friemann, R., Gómez-Puerta, S., Martinez-Fleites, C., Garrido, G., Rabasa, A., López-Requena, A., Pupo, A., Johansen, R.F., Sánchez, O., Krengel, U. and Moreno, E. (2009) Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation. Cancer Res. 69, 58515859.
  • Triguero, A., Cabrera, G., Cremata, J.A., Yuen, C.T., Wheeler, J. and Ramírez, N.I. (2005) Plant derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum retention signal is N glycosylated homogeneously throughout the plant with mostly high mannose type N glycans. Plant Biotechnol. J. 3, 449457.
  • Twyman, R.M., Schillberg, S. and Fischer, R. (2012) The production of vaccines and therapeutic antibodies in plants. In Molecular Farming in Plants: Recent Advances and Future Prospects (Wang, A. and Ma, S., eds), pp. 145159. Dordrecht, the Netherlands: Springer.
  • Valdés, R., Gómez, L., Padilla, S., Brito, J., Reyes, B., Alvarez, T., Mendoza, O., Herrera, O., Ferro, W. and Pujol, M. (2003) Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants. Biochem. Biophys. Res. Commun. 308, 94100.
  • Viloria-Petit, A., Crombet, T., Jothy, S., Hicklin, D., Bohlen, P., Schlaeppi, J.M., Rak, J. and Kerbel, R.S. (2001) Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo. Cancer Res. 61, 50905101.
  • Wilken, L.R. and Nikolov, Z.L. (2012) Recovery and purification of plant-made recombinant proteins. Biotechnol. Adv. 30, 419433.
  • Wilm, M., Shevchenko, A., Houthaeve, T., Brelt, S., Schweigerer, L., Fotsis, T. and Mann, M. (1996) Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature, 379, 466469.
  • You, B., Brade, A., Magalhaes, J.M., Siu, L.L., Oza, A., Lovell, S., Wang, L., Hedley, D.W., Nicacio, L.V. and Chen, E.X. (2010) A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies. Invest. New Drugs, 29, 9961003.
  • Zambryski, P., Joos, H., Genetello, C., Leemans, J., Van Montagu, M. and Schell, J. (1983) Ti plasmid vector for the introduction of DNA into plant cells without alteration of their normal regeneration capacity. EMBO J. 2, 2143.